Search

Search Constraints

You searched for: Author/Creator Xi, Yaming

Search Results

2. Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera®) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial. Issue 5 (12th August 2022)